There is another, troubling side to the Catalyst story.
Here's a technical look at how to trade several under-$10 triggering breakout trades.
Catalyst Pharmaceuticals' (CPRX) stock rating was boosted to 'overweight' at Piper Jaffray on Wednesday.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Catalyst Pharmaceuticals (CPRX) stock is sinking on heavy trading volume on Wednesday after the company announced that it received a 'Refusal to File' letter from the FDA.